Membrane interactions and photodynamic activity of 1,9-dimethyl methylene blue in oropharyngeal carcinoma models
L G Moreira1, M B Kobal1, S A Camacho1
1São Paulo State University (UNESP), School of Sciences, Humanities and Languages, Assis, SP 19806-900, Brazil.
Abstract:
The growing demand for alternative cancer treatments has intensified interest in photodynamic therapy (PDT), a minimally invasive approach that combines light irradiation with photosensitizing agents (PSs) to achieve localized cytotoxicity. Phenothiazine derivatives are well established as antimicrobial and anticancer PSs, positioning 1,9-dimethyl methylene blue (DMMB) as a promising candidate. However, the photodynamic performance of DMMB against oropharyngeal carcinoma, particularly as a function of photosensitizer concentration and light dose, remains poorly explored. Here, we investigate the molecular interactions and photodynamic effects of DMMB using membrane-mimetic systems based on lipid extracts from human oropharyngeal carcinoma cells (HEp-2), complemented by in vitro cellular assays. Langmuir monolayers revealed strong membrane affinity of DMMB, leading to pronounced monolayer expansion (up to ∼90% at 1.0 μmol/L) and changes in elastic properties. Upon photoactivation, DMMB induced concentration- and light dose-dependent reductions in monolayer surface area, consistent with light-triggered photodynamic effects at the membrane interface. At 0.1 μmol/L, a modest decrease of ∼3.5% was observed, whereas at 1.0 μmol/L the surface area reduction increased from 6.9% to 13.4% as the light dose rose from 1 to 18 J/cm2. FTIR spectroscopy of Langmuir-Schaefer films revealed limited spectral changes mainly associated with interfacial lipid regions, particularly carbonyl hydration and relative intensity variations, while phosphate and acyl-chain regions were largely preserved. Cellular assays were consistent with the interfacial findings. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and LDH (lactate dehydrogenase) assays demonstrated pronounced phototoxicity in HEp-2 cells with no detectable dark toxicity, yielding IC₅₀ values that decreased from 0.82 μmol/L at 1 J/cm2 to 0.35 μmol/L at 18 J/cm2. Increased LDH release and confocal fluorescence microscopy revealed plasma membrane disruption and intracellular damage consistent with light-induced membrane perturbation inferred from the monolayer studies, which may involve lipid oxidation-related processes. Overall, these results support an association between DMMB-membrane interactions and cellular phototoxicity, highlighting how photosensitizer concentration and light dose modulate DMMB photodynamic effects under the investigated experimental conditions. DMMB thus emerges as a promising candidate for further investigation in oropharyngeal carcinoma PDT models.
Insights
1,9-dimethyl methylene blue (DMMB) shows promise as a photodynamic therapy agent for oropharyngeal cancer. Its effectiveness in disrupting cancer cell membranes increases with higher concentrations and light doses, indicating potential for targeted treatment.
Area of Science:
- Biophysics
- Photochemistry
- Cancer Research
Background:
- Photodynamic therapy (PDT) is an emerging cancer treatment requiring photosensitizing agents (PSs).
- Phenothiazine derivatives are effective PSs, with 1,9-dimethyl methylene blue (DMMB) showing potential for anticancer applications.
- The photodynamic effects of DMMB on oropharyngeal carcinoma, especially concerning PS concentration and light dose, require further investigation.
Purpose of the Study:
- To investigate the molecular interactions and photodynamic effects of DMMB on oropharyngeal carcinoma.
- To evaluate the influence of DMMB concentration and light dose on its photodynamic efficacy.
- To correlate DMMB-membrane interactions with cellular phototoxicity in oropharyngeal cancer models.
Main Methods:
- Utilized membrane-mimetic systems (Langmuir monolayers and Langmuir-Schaefer films) from human oropharyngeal carcinoma cell (HEp-2) lipid extracts.
- Employed Langmuir trough and FTIR spectroscopy to analyze DMMB-lipid interactions.
- Conducted in vitro cellular assays (MTT and LDH) and confocal fluorescence microscopy to assess phototoxicity and cellular damage.
Main Results:
- DMMB exhibited strong membrane affinity, causing significant monolayer expansion and altering elastic properties.
- Photoactivation of DMMB induced concentration- and light dose-dependent reductions in monolayer surface area, indicating membrane damage.
- Cellular assays confirmed DMMB's phototoxicity against HEp-2 cells, with reduced IC50 values at higher light doses and no dark toxicity; plasma membrane disruption was observed.
Conclusions:
- DMMB demonstrates significant membrane interaction and photodynamic effects relevant to oropharyngeal carcinoma treatment.
- The photodynamic efficacy of DMMB is modulated by photosensitizer concentration and light dose, suggesting a tunable therapeutic approach.
- DMMB is a promising candidate for further development in oropharyngeal carcinoma photodynamic therapy.

